Epstein-Barr virus infection of human brain microvessel endothelial cells: A novel role in multiple sclerosis

Journal of Neuroimmunology

Volumn 230, Issue 1-2, 2011, Pages 173-177

  Casiraghi, Costanza ^a   Dorovini Zis, Katerina ^b   Horwitz, Marc S ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Blood brain barrier; Endothelial cells; Epstein Barr virus; Human brain microvessel endothelial cells; Inflammation; Multiple sclerosis

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN 1; IMMEDIATE EARLY PROTEIN BZLF1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; LATENT MEMBRANE PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ARTICLE; AUTOIMMUNITY; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; CELL ADHESION; CELL ISOLATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENCEPHALITIS; ENDOTHELIUM CELL; EPSTEIN BARR VIRUS INFECTION; GENE EXPRESSION; HUMAN; HUMAN CELL; MICROVASCULATURE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS GENOME; VIRUS REPLICATION;

BLOOD-BRAIN BARRIER; CELL ADHESION; CYTOKINES; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPSTEIN-BARR VIRUS INFECTIONS; HUMANS; LEUKOCYTES, MONONUCLEAR; MICROVESSELS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 78650983345     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.08.003     Document Type: Article

References (33)

1. Allen M.D., Young L.S., Dawson C.W. The Epstein-Barr virus-encoded LMP2A and LMP2B proteins promote epithelial cell spreading and motility. J. Virol. 2005, 79:1789-1802.
2. Ascherio A., Munger K.L. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann. Neurol. 2007, 61:288-299.
3. Ban S., Goto Y., Kamada K., Takahama M., Watanabe H., Iwahori T., Takeuchi H. Systemic granulomatous arteritis associated with Epstein-Barr virus infection. Virchows Arch. 1999, 434:249-254.
4. Bornkamm G.W., Hammerschmidt W. Molecular virology of Epstein-Barr virus. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2001, 356:437-459.
5. Brabb T., Goldrath A.W., von Dassow P., Paez A., Liggitt H.D., Goverman J. Triggers of autoimmune disease in a murine TCR-transgenic model for multiple sclerosis. J. Immunol. 1997, 159:497-507.
6. Chui R., Dorovini-Zis K. Regulation of CCL2 and CCL3 expression in human brain endothelial cells by cytokines and lipopolysaccharide. J. Neuroinflammation 2010, 7:1.
7. Dietrich J.B. The adhesion molecule ICAM-1 and its regulation in relation with the blood-brain barrier. J. Neuroimmunol. 2002, 128:58-68.
8. Dorovini-Zis K., Prameya R., Bowman P.D. Culture and characterization of microvascular endothelial cells derived from human brain. Lab. Invest. 1991, 64:425-436.
9. Feederle R., Neuhierl B., Bannert H., Geletneky K., Shannon-Lowe C., Delecluse H.J. Epstein-Barr virus B95.8 produced in 293 cells shows marked tropism for differentiated primary epithelial cells and reveals interindividual variation in susceptibility to viral infection. Int. J. Cancer 2007, 121:588-594.
10. Gosselin J., Borgeat P. Epstein-Barr virus modulates 5-lipoxygenase product synthesis in human peripheral blood mononuclear cells. Blood 1997, 89:2122-2130.
11. Guarner J., Unger E.R. Association of Epstein-Barr virus in epithelioid angiomatosis of AIDS patients. Am. J. Surg. Pathol. 1990, 14:956-960.
12. Jarvis M.A., Nelson J.A. Human cytomegalovirus tropism for endothelial cells: not all endothelial cells are created equal. J. Virol. 2007, 81:2095-2101.
13. Jebbink J., Bai X., Rogers B.B., Dawson D.B., Scheuermann R.H., Domiati-Saad R. Development of real-time PCR assays for the quantitative detection of Epstein-Barr virus and cytomegalovirus, comparison of TaqMan probes, and molecular beacons. J. Mol. Diagn. 2003, 5:15-20.
14. Jones K., Rivera C., Sgadari C., Franklin J., Max E.E., Bhatia K., Tosato G. Infection of human endothelial cells with Epstein-Barr virus. J. Exp. Med. 1995, 182:1213-1221.
15. Levin L.I., Munger K.L., Rubertone M.V., Peck C.A., Lennette E.T., Spiegelman D., Ascherio A. Temporal relationship between elevation of Epstein Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA 2005, 293:2496-2500.
16. Lunemann J.D., Munz C. EBV in MS: guilty by association? Trends Immunol. 2009, 30:243-248.
17. Lunemann J.D., Jelcic I., Roberts S., Lutterotti A., Tackenberg B., Martin R., Munz C. EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2. J. Exp. Med. 2008, 205:1763-1773.
18. Luo B., Wang Y., Wang X.F., Liang H., Yan L.P., Huang B.H., Zhao P. Expression of Epstein-Barr virus genes in EBV-associated gastric carcinomas. World J. Gastroenterol. 2005, 11:629-633.
19. Mrass P., Weninger W. Immune cell migration as a means to control immune privilege: lessons from the CNS and tumors. Immunol. Rev. 2006, 213:195-212.
20. Ota K., Matsui M., Milford E.L., Mackin G.A., Weiner H.L., Hafler D.A. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 1990, 346:183-187.
21. Pender M.P., Csurhes P.A., Lenarczyk A., Pfluger C.M., Burrows S.R. Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 2009, 80:498-505.
22. Prat A., Biernacki K., Lavoie J.F., Poirier J., Duquette P., Antel J.P. Migration of multiple sclerosis lymphocytes through brain endothelium. Arch. Neurol. 2002, 59:391-397.
23. Quandt J., Dorovini-Zis K. The beta chemokines CCL4 and CCL5 enhance adhesion of specific CD4+ T cell subsets to human brain endothelial cells. J. Neuropathol. Exp. Neurol. 2004, 63:350-362.
24. Ransohoff R.M. Immunology: in the beginning. Nature 2009, 462:41-42.
25. Savard M., Belanger C., Tardif M., Gourde P., Flamand L., Gosselin J. Infection of primary human monocytes by Epstein-Barr virus. J. Virol. 2000, 74:2612-2619.
26. Shannon-Lowe C., Adland E., Bell A.I., Delecluse H.J., Rickinson A.B., Rowe M. Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification. J. Virol. 2009, 83:7749-7760.
27. Simpson J.E., Newcombe J., Cuzner M.L., Woodroofe M.N. Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions. J. Neuroimmunol. 1998, 84:238-249.
28. Sospedra M., Martin R. Immunology of multiple sclerosis. Annu. Rev. Immunol. 2005, 23:683-747.
29. Valbuena G., Walker D.H. The endothelium as a target for infections. Annu. Rev. Pathol. 2006, 1:171-198.
30. van Veen T., Nielsen J., Berkhof J., Barkhof F., Kamphorst W., Bo L., Ravid R., Verweij C.L., Huitinga I., Polman C.H., Uitdehaag B.M. CCL5 and CCR5 genotypes modify clinical, radiological and pathological features of multiple sclerosis. J. Neuroimmunol. 2007, 190:157-164.
31. Willis S.N., Stadelmann C., Rodig S.J., Caron T., Gattenloehner S., Malozzi S.S., Roughan J.E., Almendinger S.E., Blewett M.M., Brück W., Hafler D.A., O'Connor K.C. Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain. Brain 2009, 132:3318-3328.
32. Wong D., Prameya R., Dorovini-Zis K. In vitro adhesion and migration of T lymphocytes across monolayers of human brain microvessel endothelial cells: regulation by ICAM-1, VCAM-1, E-selectin and PECAM-1. J. Neuropathol. Exp. Neurol. 1999, 58:138-152.
33. Xiong A., Clarke-Katzenberg R.H., Valenzuela G., Izumi K.M., Millan M.T. Epstein-Barr virus latent membrane protein 1 activates nuclear factor-kappa B in human endothelial cells and inhibits apoptosis. Transplantation 2004, 78:41-49.